MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by PAULSON, J. C.
Right arrow Articles by McCLURE, W. O.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by PAULSON, J. C.
Right arrow Articles by McCLURE, W. O.

Molecular Pharmacology, Vol 10, 419-424, Copyright © 1974 by the American Society for Pharmacology and Experimental Therapeutics

The Lack of Correlation between Hallucinogenesis and Inhibition of Axoplasmic Transport

JAMES C. PAULSON 1 and WLLLIAM O. McCLURE 1

1 Department of Biochemistry, University of Illinois, Urbana, Illinois 61801

Several hallucinogenic indoles were examined for an inhibitory effect upon fast axoplasmic transport of proteins in the optic system of the anesthetized rat. No inhibition was produced by milligram levels of lysergide or N,N-dimethyltryptamine, although some derivatives of N,N-dimethyltryptamine produced partial inhibition at this dose. Harmaline and 6-methoxylharmalan, which are poor hallucinogens, are active as inhibitors of transport. The hallucinogenic compound R(-)-1-(2,5-dimethoxy-4-methylphenyl)-2-aminopropane and its nonhallucinogenic enantiomer were also tested for antitransport activity in a system in vitro which utilized the rat sciatic nerve. Both enantiomers are effective inhibitors of axoplasmic transport. It is concluded that inhibition of axoplasmic transport is not correlated with hallucinogenesis, even though a good correlation of these parameters has previously been observed in studies of a series of structurally related derivatives of mescaline.

Submitted on December 26, 1973







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1974 by the American Society for Pharmacology and Experimental Therapeutics